Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berger

Showing results (681-690 of 724) with videos related to

Pageof 73
Sort By:
The Pharmacogenomics Journal|June 22, 2018
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancerMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Circulation. Arrhythmia and Electrophysiology|November 16, 2013
Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathyTakeshi Sasaki, Christopher F Miller, Rozann Hansford, et al.
ESMO Open|March 2, 2023
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastasesJ R Hecht, S S Raman, A Chan, et al.
Plos One|March 10, 2018
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patientsMarta Schirripa, Wu Zhang, Dongyun Yang, et al.
The Pharmacogenomics Journal|December 23, 2015
Genetic variants associated with colorectal brain metastases susceptibility and survivalS Stremitzer, A S Berghoff, N B Volz, et al.
Circulation Research|October 6, 2007
Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablationHiroshi Ashikaga, Tetsuo Sasano, Jun Dong, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2025
Caffeine-associated reduction in patent ductus arteriosus is mediated in part by adenosine receptor antagonismStacey L Crockett, Rachel L Su, Deanna C Sekulich, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, et al.
Clinical Colorectal Cancer|November 13, 2024
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16Sara Bastian, Markus Joerger, Lisa Holer, et al.
Leukemia|December 19, 2017
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cellsB Peter, S Bibi, G Eisenwort, et al.
Pageof 73

Showing results (681-690 of 724) with videos related to

Sort By:
Pageof 73
The Pharmacogenomics Journal|June 22, 2018
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancerMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Circulation. Arrhythmia and Electrophysiology|November 16, 2013
Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathyTakeshi Sasaki, Christopher F Miller, Rozann Hansford, et al.
ESMO Open|March 2, 2023
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastasesJ R Hecht, S S Raman, A Chan, et al.
Plos One|March 10, 2018
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patientsMarta Schirripa, Wu Zhang, Dongyun Yang, et al.
The Pharmacogenomics Journal|December 23, 2015
Genetic variants associated with colorectal brain metastases susceptibility and survivalS Stremitzer, A S Berghoff, N B Volz, et al.
Circulation Research|October 6, 2007
Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablationHiroshi Ashikaga, Tetsuo Sasano, Jun Dong, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2025
Caffeine-associated reduction in patent ductus arteriosus is mediated in part by adenosine receptor antagonismStacey L Crockett, Rachel L Su, Deanna C Sekulich, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, et al.
Clinical Colorectal Cancer|November 13, 2024
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer: A Multicenter Phase Ib Trial (RECAP)-SAKK 41/16Sara Bastian, Markus Joerger, Lisa Holer, et al.
Leukemia|December 19, 2017
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cellsB Peter, S Bibi, G Eisenwort, et al.
Pageof 73